January 3, 2008Open Access

Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

Key Points

Key points are not available for this paper at this time.

Abstract

The addition of 4 months of ADT to EBRT appears to have a dramatic impact on clinically meaningful end points in men with locally advanced disease with no statistically significant impact on the risk of fatal cardiac events.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

Roach et al. (Thu,) studied this question.

synapsesocial.com/papers/69d850d5f4e559c61eae36fd https://doi.org/https://doi.org/10.1200/jco.2007.13.9881

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation Therapy2006 · 588 citations
2The case for neoadjuvant androgen suppression before radiation therapy.2000 · 11 citations
3Neoadjuvant Hormonal Therapy Before Radical Prostatectomy Decreases the Number of Positive Surgical Margins in Stage T2 Prostate Cancer1995 · 112 citations
4A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma2002 · 1,657 citations
5A randomized trial comparing conventional dose (70.2GyE) and high-dose (79.2GyE) conformal radiation in early stage adenocarcinoma of the prostate: Results of an interim analysis of PROG 95–092004 · 37 citations

AI से पूछें

Bookmark

View Full Paper